MicroRNA-494 promoting functional recovery and inhibiting apoptosis after spinal cord injury

顾士欣,顾文韬,刘晓东,寿佳俊,车晓明
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2020.03.025
2020-01-01
Abstract:Objective:To study the role and significance of microRNA (miRNA, miR)-494 in spinal cord injury.Methods:A spinal cord injury model was established by contusion of the spinal cord surface, and the animals were divided into a sham injury control group and 5 spinal cord injury groups, 5 rats in each group (Animals were purchased from shanghai fudan university laboratory animal center). miRNA chips were used to analyze the expression of miRNA at different time points after spinal cord injury. After intrathecal treatment with agomir-494, the motor function of rats was evaluated.Results:As compared with the sham injury control group, 14 miRNAs were up-regulated and 46 miRNAs were down-regulated by two folds, and miR-494 was one of the most significantly down-regulated miRNAs.Compared with the SCI group alone, in the SCI + agomiR-494 group after intrathecal treatment with agomiR-494, the motor function of rats was significantly improved, the remaining tissues (cresyl violet staining assessment) increased, and the number of TUNEL positive cells decreased. The up-regulation of agomiR-494 on miR-494 could promote functional recovery in rats after spinal cord injury, reduce lesion size and inhibit apoptotic cells. The expression of miR-494 in spinal cord tissue was negatively correlated with phosphatase and tensin homologue deleted on chromosome ten (PTEN) expression ( r=-0.834, P<0.05). In addition, miR-494 could inhibit the negative regulators of the protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway, phosphatase and PTEN, by directly targeting the 3’ untranslated regions (3’UTR) in BV-2 cells. Conclusion:MiR-494 overexpression in rat spinal cord injury models activates the Akt/mTOR signaling pathway by inhibiting the expression of PTEN, which has a protective effect on spinal cord injury and is a potential candidate gene for treatment.
What problem does this paper attempt to address?